Continuing HIV therapy in the ICU
The risks and benefits of stopping antiretroviral therapy in patients admitted to the ICU are largely unmeasured. In many cases therapy has to be stopped, as parenteral preparations are unavailable for all but one of the antiretroviral agents. Stopping treatment suddenly may be associated with incre...
Guardat en:
| Publicat a: | Crit Care |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2001
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137283/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11737898/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cc1040 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|